Robotic versus laparoscopic radical hysterectomy in early cervical cancer: A case matched control study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published Date:

Abstract

BACKGROUND: This study aims at evaluating the feasibility, surgical outcome and oncological results observed after robotic radical hysterectomy (RH) compared to laparoscopy for patients with early stage cervical cancer (ECC) patients.

Authors

  • Valerio Gallotta
    Division of Gynecologic Oncology, Fondazione "Policlinico Universitario A. Gemelli", Catholic University of the Sacred Heart, Rome, Italy. Electronic address: gallottav@gmail.com.
  • Carmine Conte
    Division of Gynecologic Oncology, Fondazione "Policlinico Universitario A. Gemelli", Catholic University of the Sacred Heart, Rome, Italy.
  • Alex Federico
    Institute of Obstetrics and Gynecology, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Giuseppe Vizzielli
    Division of Gynecologic Oncology, Fondazione "Policlinico Universitario A. Gemelli", Catholic University of the Sacred Heart, Rome, Italy.
  • Salvatore Gueli Alletti
    Division of Gynecologic Oncology, Fondazione "Policlinico Universitario A. Gemelli", Catholic University of the Sacred Heart, Rome, Italy.
  • Lucia Tortorella
    Division of Gynecologic Oncology, Fondazione "Policlinico Universitario A. Gemelli", Catholic University of the Sacred Heart, Rome, Italy.
  • Luigi Pedone Anchora
    Division of Gynecologic Oncology, Fondazione "Policlinico Universitario A. Gemelli", Catholic University of the Sacred Heart, Rome, Italy.
  • Francesco Cosentino
    Division of Gynecologic Oncology, Fondazione "Policlinico Universitario A. Gemelli", Catholic University of the Sacred Heart, Rome, Italy.
  • Vito Chiantera
    Division of Gynecologic Oncology, University of Palermo, Palermo, Italy.
  • Anna Fagotti
    Department of Women's, Child and Public Health Sciences, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
  • Marco D'Indinosante
    Division of Gynecologic Oncology, Fondazione "Policlinico Universitario A. Gemelli", Catholic University of the Sacred Heart, Rome, Italy.
  • Silvia Pelligra
    Division of Gynecologic Oncology, Fondazione "Policlinico Universitario A. Gemelli", Catholic University of the Sacred Heart, Rome, Italy.
  • Giovanni Scambia
    Division of Gynecological Oncology, Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy.
  • Gabriella Ferrandina
    Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy.